Scissortail Wealth Management LLC Purchases New Shares in Encompass Health Co. (NYSE:EHC)

Scissortail Wealth Management LLC acquired a new position in Encompass Health Co. (NYSE:EHC) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 15,462 shares of the company’s stock, valued at approximately $1,107,000.

Several other large investors have also added to or reduced their stakes in the stock. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Encompass Health during the 4th quarter worth approximately $30,000. C M Bidwell & Associates Ltd. acquired a new position in shares of Encompass Health during the third quarter valued at approximately $35,000. Worth Asset Management LLC purchased a new stake in shares of Encompass Health in the first quarter valued at approximately $35,000. Belpointe Asset Management LLC grew its position in Encompass Health by 88.2% in the first quarter. Belpointe Asset Management LLC now owns 781 shares of the company’s stock worth $42,000 after acquiring an additional 366 shares during the period. Finally, Quarry LP acquired a new stake in shares of Encompass Health in the first quarter valued at $42,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

NYSE:EHC traded down $0.75 during midday trading on Tuesday, reaching $79.98. The stock had a trading volume of 721,965 shares, compared to its average volume of 651,841. The firm has a fifty day simple moving average of $77.01 and a two-hundred day simple moving average of $70.09. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $83.73. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. The stock has a market cap of $8.01 billion, a P/E ratio of 23.05, a P/E/G ratio of 1.49 and a beta of 0.94.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.12. The business had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.24 billion. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. On average, equities analysts expect that Encompass Health Co. will post 3.96 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were paid a $0.15 dividend. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.60 dividend on an annualized basis and a yield of 0.75%. Encompass Health’s dividend payout ratio is currently 17.29%.

Wall Street Analysts Forecast Growth

EHC has been the subject of several research reports. Barclays lifted their price objective on Encompass Health from $95.00 to $101.00 and gave the stock an “overweight” rating in a research report on Thursday, March 28th. Mizuho upped their target price on shares of Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, February 9th. Royal Bank of Canada reiterated an “outperform” rating and set a $83.00 price objective on shares of Encompass Health in a research note on Friday, February 9th. Truist Financial lifted their target price on shares of Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research note on Friday, February 9th. Finally, Stephens reiterated an “overweight” rating and issued a $85.00 target price on shares of Encompass Health in a report on Tuesday, January 16th. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $83.22.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.